1.
J Investig Allergol Clin Immunol
; 31(3): 261-263, 2021 Jun 22.
Article
in English
| MEDLINE
| ID: mdl-32732182
Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Asthma/drug therapy , Dermatitis, Atopic/drug therapy , Hypereosinophilic Syndrome/drug therapy , Inflammation/drug therapy , Th2 Cells/immunology , Cytokines/metabolism , Humans , Interleukin-4/antagonists & inhibitors , Interleukin-4 Receptor alpha Subunit/immunology , Male , Young Adult
2.
J. investig. allergol. clin. immunol
; 31(3): 261-263, 2021. tab
Article
in English
| IBECS
| ID: ibc-215211
Subject(s)
Humans , Male , Young Adult , Antibodies, Monoclonal, Humanized/therapeutic use , Asthma/drug therapy , Dermatitis, Atopic/drug therapy , Hypereosinophilic Syndrome/drug therapy , Inflammation/drug therapy , Th2 Cells/immunology , Interleukin-4 Receptor alpha Subunit/immunology , Interleukin-4/antagonists & inhibitors , Cytokines/metabolism
3.
Clin Exp Dermatol
; 45(3): 345-346, 2020 Apr.
Article
in English
| MEDLINE
| ID: mdl-31437869
4.
J Eur Acad Dermatol Venereol
; 33 Suppl 6: 34-35, 2019 Oct.
Article
in English
| MEDLINE
| ID: mdl-31535757
ABSTRACT
Literature data about hidradenitis suppurativa (HS) in patients with Down syndrome (DS) are limited. In this retrospective study, 6 (4M/2F; mean age: 18.7 years) out of 313 patients affected by HS (1.9%) had DS. The age of appearance of HS was from 9 to 14 years. No family history of HS was present. BMI ranged from 20.1 to 29.9. In all patients, HS was located below the diaphragm. Five out of six patients were staged as Hurley II severity.
